Note 16 - Stockholders' Equity

3 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

1 6 . STOCKHOLDERS’ EQUITY

Summary

The following table summarizes changes in the components of stockholders’ equity during the

three

months ended

December 31, 2019

and the

three

months ended

December 31, 2018:

										Accumulated
					Additional					Other			Total
	Common Stock				Paid-in		Accumulated			Comprehensive			Stockholders'
	Shares		Amount		Capital		Deficit			Loss			Equity
Balance at September 30, 2019		32,949,987		330	$	89,571,641	$	(53,731,903	)	$	(458,719	)	$	35,381,349
Share-based compensation expense		-		-		158,327		-			-			158,327
Issuance of common stock upon exercise of stock options, net		83,343		1		144,213		-			-			144,214
Issuance of common stock upon vesting of restricted stock units		-		-		-		-			-			-
Other comprehensive income (loss)		-		-		-		-			85,314			85,314
Net income		-		-		-		620,327			-			620,327
Balance at December 31, 20119		33,033,330		331	$	89,874,181	$	(53,111,576	)	$	(373,405	)	$	36,389,531

													Accumulated
							Additional						Other			Total
	Common Stock						Paid-in			Accumulated			Comprehensive			Stockholders'
	Shares			Amount			Capital			Deficit			Loss			Equity
Balance at September 30, 2018		33,176,146		$	332		$	90,251,145		$	(56,516,895	)	$	(245,375	)	$	33,489,207
Share-based compensation expense		-			-			133,845			-			-			133,845
Issuance of common stock upon exercise of stock options, net		1,600			-			2,528			-			-			2,528
Issuance of common stock upon vesting of restricted stock units		-			-			-			-			-			-
Stock buyback		(588,425	)		(6	)		(1,621,016	)		-			-			(1,621,022	)
Other comprehensive loss		-			-			-			-			(54,335	)		(54,335	)
Net income		-			-			-			1,045,940			-			1,045,940
Balance at December 31, 2018		32,589,321		$	326		$	88,766,502		$	(55,470,955	)	$	(299,710	)	$	32,996,163

Common Stock Activity

During the

three

months ended

December 31, 2019,

the Company issued

83,343

shares of common stock and obtained gross proceeds of

$144,214

in connection with the exercise of stock options. During the

three

months ended

December 31, 2018,

the Company issued

1,600

shares of common stock and obtained gross proceeds of

$2,528

in connection with the exercise of stock options.

Share Buyback Program

The Board of Directors approved a share buyback program in

2015

under which the Company was authorized to repurchase up to

$4

million of its outstanding common shares. In

December 2017,

the Board of Directors extended the program through

December 31, 2018.

In

December 2018,

the Board of Directors approved a new share buyback program beginning

January 1, 2019

and expiring on

December 31, 2020,

under which the Company was authorized to repurchase up to

$5

million of its outstanding common shares. The previous program expired on

December 31, 2018.

During the

three

months ended

December 31, 2019

no

shares were repurchased by the Company. During the

three

months ended

December 31, 2018,

588,425

shares were repurchased for

$1,621,022.

All repurchased shares were retired.

Dividends

There were

no

dividends declared in the

three

months ended

December 31, 2019

and

2018.